Novavax (NVAX) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.27 +3.00%
EPS Growth %: -164.5%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -164.5%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.29), $0.02 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $10.39 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Worthington Enterprises raises dividend 5%, adds board member
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
